Article ID Journal Published Year Pages File Type
7802259 European Journal of Medicinal Chemistry 2012 8 Pages PDF
Abstract
► We coupled dabigatran with HTMP via esterification to afford seven new prodrugs. ► Y-2, One of our compounds, showed more potent activity for inhibiting thrombosis in vivo than that of dabigatran etexilate. ► In a certain sense, ADP-induced platelet aggregation test indicated the more potent activity of Y-2 was due to HTMP. ► Pharmacokinetic evaluation proved that Y-2 could be metabolized into dabigatran and HTMP.
Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , ,